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http://cme.ctsnetjournals.org286 The Journal of Thoracic and Cardbjective: This study investigated whether postoperative low cardiac output and
ortality in obstructed total anomalous pulmonary venous connection could be
educed by selective vertical vein patency.
ethods: Fifty-eight patients undergoing rechanneling of total anomalous pulmo-
ary venous connection between 1997 and 2006 were studied. The vertical vein was
eft patent in 27 patients (group I) and ligated in 31 (group II). Mean ages were 1.49
.63 and 4.37  3.38 months for groups I and II, respectively.
esults: Operative mortalities were 29.1% and 7.4% for ligated and unligated
roups, respectively (relative risk 1.75, 1.16-2.64, P  .036). Age younger than 1
onth, obstructive total anomalous pulmonary venous connection, hypoplastic
ulmonary veins, pulmonary hypertensive crisis, low cardiac output, and vertical
ein ligation were significant risk factors for death according to logistic regression
nalysis. Patients with obstructed total anomalous pulmonary venous connection
ndergoing vertical vein ligation demonstrated predominant right ventricular dys-
unction (relative risk 2.93, 1.28-6.73, P  .011), pulmonary hypertensive crisis
relative risk 2.90, 1.25-6.75, P  .013), and 3.28 times the risk of death (95%
onfidence interval 1.08-9.99, P  .032) relative to the unligated group.
onclusions: In a subset of patients with obstructed total anomalous pulmonary
enous connection, an unligated vertical vein reduces pulmonary arterial pressure,
ecreases perioperative pulmonary hypertensive crises, provides a temporary pop-
ff valve during pulmonary hypertensive crisis, and improves survival by providing
uperior hemodynamics. The high mortality in the ligated group suggests that
atients with obstructed total anomalous pulmonary venous connection with post-
ypass moderate pulmonary hypertension possibly should not undergo vertical vein
igation. We propose routine use of an adjustable ligature around the vertical vein
n all patients with more than moderate post-bypass pulmonary hypertension,
llowing gradual tightening in increments without multiple reoperations.
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Despite improvements during the past decade in pe-
diatric anesthesia, intensive care, and myocardial
protection, repair of obstructive total anomalous
ulmonary venous connection (TAPVC) continues to be
ssociated with significant mortality, reportedly ranging
rom 10% to 50%.1-5 In 1999, we reported worse outcomes
f TAPVC repair as a result of delayed referral, accounting
or cardiac cachexia, emergency operation, pulmonary in-
ection, and severe pulmonary artery (PA) hypertension.5
Studies have documented that in the presence of obstruc-
ive pulmonary venous drainage, the left-sided chambers are
maller than those in nonobstructive cases.6-9 Despite inno-
ative surgical techniques to increase the dimension of the
eft atrial (LA) cavity and pharmacologic manipulations to
ombat pulmonary hypertensive crisis, low cardiac output
emains a significant problem, leading to hemodynamic
nstability and morbidity after surgery.1-9
From these observations, it has been hypothesized that a
atent vertical vein may function as a temporary reservoir
or pulmonary venous blood after TAPVC repair, volume
nloading the small, noncompliant, left-sided cardiac cham-
ers until they are able to grow and adapt to the increased
ow demands.8-11 Not all investigators and surgeons have
ccepted these findings or used these techniques. To inves-
igate this hypothesis, this study aimed first to ascertain
hether the practice of routine ligation of vertical vein is
ecessary, second to examine the effects of selective patent
ertical vein on postoperative hemodynamics, third to com-
are the outcomes of patients undergoing interruption of the
ertical vein with those in whom it was left unligated, and
ourth to determine the long-term fate of the unligated
ertical vein.
atients and Methods
riteria for Decision Making and Selection of Patients
his prospective study evaluated outcomes after selective use of
ertical vein ligation in a consecutive series of patients undergoing
epair of isolated TAPVC. Only patients with type I, III, or IV
APVC with a discernible ascending or descending vertical vein
ere included in this study. The decision to keep the vertical vein
Abbreviations and Acronyms
ASD  atrial septal defect
CI  confidence interval
CPB  cardiopulmonary bypass
LA  left atrium
PA  pulmonary artery
RR  relative risk
SPAP  systolic pulmonary arterial pressure
TAPVC total anomalous pulmonary venous
connectionatent was made after the occurrence of elevated PA pressure p
The Journal of Thoracicsystemic or suprasystemic) after coming off cardiopulmonary
ypass (CPB) and untoward hemodynamic effects on snaring the
ertical vein. All patients with nonobstructed TAPVC without
ulmonary hypertension and patients with obstructed TAPVC with
oderate post-CPB pulmonary hypertension (systolic PA pressure
SPAP] 31-50 mm Hg) underwent vertical vein ligation. Thus,
here were four forces driving our criteria for selection of patients
n whom the vertical vein was kept patent after rechanneling of
APVC: (1) the desire to reduce the PA pressure in the perioper-
tive period after achievement of an adequately sized, unrestrictive
nastomosis along with pharmacologic manipulations; (2) the de-
ire to reduce pulmonary hypertensive crises, low cardiac output,
nd in-hospital mortality after repair of TAPVC with pulmonary
ypertension; (3) the desire that the unligated vertical vein serve as
temporary pop-off valve in the event of pulmonary hypertensive
rises; and (4) the desire that the unligated vertical vein function as
temporary venous reservoir for pulmonary venous blood, volume
nloading the small, noncompliant left-sided cardiac chambers
ntil they were able to grow and adapt to the requisite flow
emands.
We excluded all patients with anomalous pulmonary venous
rainage to the right superior vena cava, coronary sinus, or right
trium who lacked a discernible vertical vein (n  5). We also
xcluded children with associated complex lesions, such as atrio-
entricular canal, transposition of the great arteries, or functionally
niventricular heart (n  3).
emographics and Preoperative Evaluation
o test our postulates, we embarked on a program of not ligating
he vertical vein in selected patients undergoing TAPVC repair at
ur institution. All patients in this study population were operated
n by a single surgeon (U.K.C.), making uniformity in the surgical
rotocol possible. The patients were entered in the study protocol
fter informed consent had been obtained from their parents or
uardians. Fifty-eight consecutive patients undergoing rechannel-
ng of isolated TAPVC from January 1997 through March 2006 at
ll India Institute of Medical Sciences, New Delhi, were included
n this prospective study (Figure E1). In this study, 27 patients
46.5%) underwent rechanneling of TAPVC without vertical vein
igation (group I), and 31 patients (53.5%) underwent vertical vein
igation (group II). Their demographic and clinical profiles are
epicted in Table 1.
Patient age at operation ranged from 1 day to 8 months (mean
.49  1.63 months, median 1 month) among those who did not
ndergo vertical vein ligation and from 1 to 12 months (mean 4.37
.37 months, median 3 months) among those who did. Fourteen
atients (24.1%) were younger than 1 month, and 9 (15.5%)
atients were between 6 and 12 months (Figure E2). Because of
he uses of selective ligation, there were significant differences in
he baseline characteristics of the two groups (Table 1). Most
atients in this study group were small for age and 53.5% weighed
ess than the 50th percentile of predicted weight for Indian neo-
ates and infants.
Echocardiography was our principal diagnostic modality.
ransthoracic 2-dimensional, color flow, Doppler echocardiogra-
hy was performed (Sonos 5500; Hewlett-Packard Company, Palo
lto, Calif), and patients were categorized according to the site of
ulmonary venous drainage. Cardiac catheterization and angiocar-
and Cardiovascular Surgery ● Volume 133, Number 5 1287
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DABLE 1. Demographic, operative, and postoperative details of the study group
Group I Group II P value
o. of patients (n  58) 27 (46.5%) 31 (53.5%)
ge (mo, mean  SD) 1.49 1.63 4.37 3.38 .001
eight (kg, mean  SD) 3.75 1.08 5.19 1.54 .001
APVC (No.) .11
Obstructive (n  30) 17 (63) 13 (42)
Nonobstructive (n  28) 10 (37) 18 (58)
natomy (No.) .09
Supracardiac (n  53) 25 (92.6%) 28 (90.3%)
Infracardiac (n  2) 2 (7.4%) 0
Mixed (n  3) 0 3 (9.7)
ulmonary arterial hypertension (No.) .001
Yes (n  46) 27 (100%) 19 (61.3%)
No (n  12) 0 12 (38.7%)
reoperative hemodynamic data
Systolic PAP (No.) .001
18 mm Hg (n  12) 0 12 (38.7%)
19-30 mm Hg (n  2) 0 2 (6.4%)
31-50 mm Hg (n  14) 7 (25.9%) 7 (22.6%)
50 mm Hg (n  30) 20 (74.1%) 10 (32.3%)
Mean PAP in patients with systolic PAP 18 mm Hg (No., n  46) 58.8 9.5 (n  27) 54.8 8.5 (n  19) .15
RVSP/LVSP (No.) .001
1.2  0.2 (n  30) 20 (74.1%) 10 (32.2%)
0.7  0.2 (n  28) 7 (25.9%) 21 (67.8%)
reoperative arterial pH (mean  SD) 7.22 0.05 7.36 0.04 .001
reoperative PaO2 (mm Hg, mean  SD) 35  7 48  5 .001
reoperative mechanical ventilation (No.) .016
Yes (n  9) 8 (29.6%) 1 (3.2%)
No (n  49) 19 (70.4%) 30 (96.8%)
reoperative inotropes (No.) .004
Yes (n  13) 11 (40.7%) 2 (6.5%)
No (n  45) 16 (59.3%) 29 (93.5%)
peration timing (No.) .009
Emergency (n  28) 18 (66.7%) 10 (32.2%)
Elective (n  30) 9 (33.3%) 21 (67.8%)
n-hospital mortality (No.)
Overall 2 (7.4%) 9 (29.1%) .04
Cardiac and pulmonary hypertension related 2 (7.4%) 8 (25.8%) .09
ulmonary hypertensive crises (No.) .001
Yes (n  23) 4 (14.8%) 19 (61.3%)
No (n  35) 23 (85.2%) 12 (38.7%)
ow cardiac output (No.) .001
Yes (n  25) 5 (18.5%) 20 (64.5%)
No (n  33) 22 (81.5%) 11 (35.5%)
uration of mechanical ventilation (d) .001
Mean  SD 35 2 6.5  3
Range 1-7 2-20
CU stay (d, mean  SD) 7.26 6.13 15.25 8.73 .001
ospital stay (d, mean  SD) 14.70  4.24 23.74 10.0 .001
ostoperative hemodynamic data in patients with preoperative
systolic PAP 18 mm Hg (n  46)
Mean PAP (mm Hg, mean  SD) 34 5 45  4 .001
Mean ABP (mm Hg, mean  SD) 64 5 48  3 .001
Mean LAP (mm Hg, mean  SD) 12 2 19  3 .001
Arterial blood pH (mean  SD) 7.46 0.05 7.27 0.03 .001
APVC, Total anomalous pulmonary venous connection; PAP, pulmonary arterial pressure; RVSP/LVSP, right-to-left ventricular systolic pressure ratio; ICU,
ntensive care unit; ABP, arterial blood pressure; LAP, left atrial pressure.
288 The Journal of Thoracic and Cardiovascular Surgery ● May 2007
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Diography were performed in 9 patients in whom an accurate
natomic pattern of pulmonary venous return was not established
y echocardiography and in 10 patients to evaluate the degree of
A hypertension. Of the 58 patients, 53 (91.3%) had a supracar-
iac connection, 2 (3.5%) had an infracardiac connection, and 3
5.2%) had a combination of supracardiac and intracardiac pulmo-
ary venous connections.
Obstructed pulmonary venous drainage was present in 30 pa-
ients (51.8%). Of these obstructed drainages, 28 (93.3%) were
upracardiac and 2 (6.7%) were infracardiac. The level of obstruc-
ion in the supracardiac variety (n 28) was located at the vertical
ein–innominate vein junction. This includes 2 cases in which
reoperative balloon dilation of the vertical vein was performed.
he ductus arteriosus was patent in 32 patients. Nine patients
15.5%) required mechanical ventilation before surgery for respi-
atory distress, and 13 patients (22.4%) required inotropic support
or hemodynamic instability. The PA pressure was measured in all
atients before the institution of CPB (Table 1).
efinitions
chocardiography was our principal diagnostic modality, and 39
f the 58 patients proceeded to operation with only echocardio-
raphic data. The indications of preoperative cardiac catheteriza-
ion were (1) anatomy that was unresolved by echocardiography,
2) characterization of the pulmonary venous obstruction, or (3)
xclusion of major associated cardiac anomalies that required
elineation or intervention.
Preoperative pulmonary venous drainage was considered ob-
tructive if there was echocardiographic (n  20/58) or angio-
raphic (n  10/58) data that indicated: (1) a significant gradient
etween the pulmonary veins and their point of drainage (flow
cceleration 2 m/s by echocardiography or pressure gradient 4
m Hg), (2) monophasic and continuous Doppler flow pattern in
he individual pulmonary veins, the pulmonary venous confluence
r the vertical vein, or (3) angiographically evident localized
eduction in a single pulmonary vein diameter of 50% or more.
ulmonary hypertension was defined as a right-to-left ventricular
ystolic pressure ratio of 0.6. According to SPAP, as measured by
ardiac catheterization or on echocardiography on the basis of the
elocity of tricuspid regurgitation, pulmonary hypertension was
raded as follows: none (SPAP 18 mm Hg), mild (SPAP 19-30
m Hg), moderate (SPAP 31-50 mm Hg), or severe (SPAP 50
m Hg.) Isolated or simple TAPVC was diagnosed if the patient
ad TAPVC in association with a secundum atrial septal defect
ASD), a patent ductus arteriosus, or both. An operation was
lassified as an emergency if the patient was taken to the operating
oom within the first 24 hours after arrival at the hospital for
emodynamic or ventilatory compromise.
Low cardiac output syndrome in repaired TAPVC was diag-
osed if the patient required inotropic support (dopamine at 4-10
g/[kg · min]), dobutamine at 5-10 g/[kg · min], epinephrine at
.01-0.1 g/[kg · min], milrinone at 50 g/kg intravenous bolus
ollowed by 0.375-0.75 g/[kg · min]), either isolated or in com-
ination in the operating room or in the intensive care unit, to
aintain stable hemodynamics in the absence of residual structural
esions and mechanical external compression after correction of all
lectrolytes or blood gas abnormalities and after adjustment of the
reload to its optimal value. Low-output syndrome was also diag- i
The Journal of Thoracicosed if there was an increasing requirement of the previously
entioned inotropes along with afterload reduction with sodium
itroprusside. Patients who received less than 4 g/(kg · min)
opamine to increase renal perfusion were not considered to have
ow output syndrome.
Invasive monitoring to measure cardiac output directly (ther-
odilution catheter, PA pressure line, and thermistors) is cumber-
ome and hazardous in children and generally avoided in our setup,
xcept in complex cases. We generally limit intracardiac monitor-
ng to right atrial, LA, and PA pressure lines.
Accordingly, under the definition of low output syndrome after
epaired TAPVC, an integration of relevant clinical, laboratory,
nd bedside echocardiographic criteria was used. The criteria for
iagnosis were as follows: cold extremities, absent pedal pulses,
ecreased toe temperature, reduced systolic pressure, impaired
enal function and oliguria (1.0 mL/[kg · hr]), metabolic acido-
is, increased serum lactate levels (2 mmol/L for 2 hours), low
ixed venous oxygen saturation (50%), and blunted sensorium
n the absence of residual anastomotic or pulmonary venous
bstruction.
perative and Postoperative Management
he surgical techniques and intraoperative and postoperative man-
gement protocols were uniform throughout the study period.
wenty-eight patients (48.3%) required emergency surgical inter-
ention for hemodynamic or respiratory compromise. The opera-
ions were performed with moderately hypothermic CPB through
ngled venous cannulas into the superior and inferior caval veins
nd aortic cannulation. Cold hyperkalemic blood cardioplegia and
opical hypothermia were used for myocardial protection. After
outine ligation of patent ductus arteriosus at the commencement
f CPB, cooling was started. During the cooling phase, the vertical
ein was dissected extrapericardially and looped. In patients with
upracardiac connection draining into the innominate vein and
nfracardiac connection, the apex of the heart was lifted cephalad
nd to the right, with the right pleural cavity wide open. This
llowed excellent exposure.
Long, transverse incisions were made on the common pulmo-
ary venous chamber and the LA. A large anastomosis (2.5–3 cm,
r as large as the calculated mitral valve orifice area) was made
etween these two chambers from outside with a running 6-0
olypropylene suture (Vicryl; Ethicon Inc, Somerville, NJ). ASDs
ere closed either through a separate right atriotomy or through
he same LA incision. For patients with large ASDs, we used
acron polyester fabric or pericardial patches to close the atrial
eptum, extending it to the right of the anastomosis of the pulmo-
ary venous sinus. This not only served to enhance the capacity of
he LA but also ensured an adequately sized communication be-
ween the pulmonary vein and the LA. In the mixed type of
rainage, repair was accomplished through a combination of
ransatrial and apical approaches.
In this series, we maintained patency of the foramen ovale or
SD in patients with obstructive supracardiac and infracardiac
ype of lesions with PA hypertension (n  30) for decompression
f the right-sided chambers in the event of pulmonary hypertensive
rises. We proceeded to keep the vertical vein unligated if the PA
ressure remained elevated (systemic or suprasystemic) after com-
ng off CPB on snaring the vertical vein. LA and PA pressures
and Cardiovascular Surgery ● Volume 133, Number 5 1289
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Dere monitored continuously after the operation. After the opera-
ion, patients were sedated and paralyzed during the first 24 to 48
ours. PA hypertension was treated with hyperventilation, seda-
ion, phenoxybenzamine, sildenafil citrate (INN sildenafil), and
nhaled nitric oxide (10-15 ppm) in varying combinations.
Eleven patients with unligated vertical veins continued to ex-
ibit signs and symptoms of right heart failure as a result of a large
eft-to-right shunt. The vertical vein was subsequently ligated
hrough a resternotomy in 4 patients, a left anterolateral thoracot-
my in 2 patients, and a percutaneously adjustable vertical vein
igature in 5 patients between 1 and 2 postoperative weeks.
The sternum was left open in 8 patients. Delayed sternal closure
as done 24 to 48 hours after hemodynamic stability was
chieved. Median duration of inotrope requirement was 7 days
range 5-18 days). Median duration of ventilation was 6 days
range 2-20 days). Twenty-six patients received total parenteral
utrition commencing after 48 hours of ventilation. After the
peration, patients were weaned from digoxin, diuretics, phenoxy-
enzamine, and angiotensin-converting enzyme-inhibitors at vary-
ng intervals.
The mean CPB time was 42 minutes (range 32–70 minutes),
nd the mean aortic crossclamp time was 32 minutes (range 25–42
inutes). Left ventricular assist devices and extracorporeal mem-
rane oxygenation were not used for any patient in this study
roup.
tatistical Analysis
ata were analyzed with STATA 9.0 (Stata Corporation, College
tation, Tex). Continuous and interval-related data are presented
s mean  SD, whereas categoric variables are presented as
requency distribution and percentages. Qualitative data were an-
lyzed with the 2 test, and quantitative data were analyzed with
he Student t-test.
Mortalities were calculated depending on the total number of
ears of follow-up for each patient. Actuarial estimates were
alculated with the Kaplan–Meier technique, and the log-rank test
as performed to analyze statistically the difference in survival
etween patients undergoing rechaneling of TAPVC with versus
ithout vertical vein ligation (Figure E3).
Univariate logistic regression was performed to calculate the
elative risk (RR) and the 95% confidence interval (CI) for each
ndependent variable. A multivariate forward stepwise logistic
egression model was used to identify independent risk factors for
n-hospital mortality. Selection of independent variables was a
orward stepwise method with critical P values of .10 and .15 for
ariable inclusion and exclusion, respectively. Vertical vein liga-
ion was used as a potential explanatory variable along with other
andidate variables (Tables E1 and E2). Two-tailed probability
as used in all the statistical tests.
esults
hort-term Results
he operative mortalities were 29.1% and 7.4% for the
igated and unligated groups, respectively (RR 1.75, 95% CI
.16-2.64, P  .036). The deaths (n  11, 18.9%) were due
o persistent postoperative PA hypertension and low cardiac
utput (group I n  2, group II n  6), massive pulmonary g
290 The Journal of Thoracic and Cardiovascular Surgery ● Maemorrhage (group II n 1), refractory ventricular arrhyth-
ias (group II n  1), and sepsis (group II n  1).
The operative mortalities were 30% (n  9/30) for pa-
ients with obstructive TAPVC and 7.2% (n  2 /28) with
onobstructive TAPVC (RR 1.83, 95% CI 1.2-2.79, P 
026). In the obstructed TAPVC group (n  30), perioper-
tive mortalities were 53.8% for patients who underwent
ertical vein ligation and 11.8% for those did not; this
ifference was statistically significant (21)  6.21, RR
.72, 95% CI 1.27-5.83, P  .02).
After the operation, 54 patients exhibited an entirely
atisfactory primary repair (echocardiography showing a
arge anastomosis, as large as or larger than mitral valve
rifice area, with no gradient between the pulmonary venous
onfluence and LA and nonturbulent biphasic pulmonary
enous flow at less than 1.2 m/s), and 4 patients demon-
trated subtle echocardiographic changes with a large unre-
trictive anastomosis with no gradient between common
ulmonary venous chamber and LA and biphasic or nearly
iphasic pulmonary venous flow with a velocity of 1.2 to
.6 m/s.
Patients with nonobstructed venous drainage without
ulmonary hypertension (supracardiac, n  12) underwent
ertical vein ligation without hemodynamic instability.
owever, 56.7% of patients (n  17/30) with preoperative
bstructed pulmonary venous drainage and 35.7% of pa-
ients (n  10/28) with nonobstructed pulmonary venous
rainage with pulmonary hypertension had varying degrees
f hemodynamic deterioration after repair. Loosening of the
ertical vein resulted in a significant decrease of the PA and
A pressures in all patients (P  .001). This was associated
ith a significant increase in mean arterial blood pressure
nd correction of metabolic acidosis in all cases (Tables 1
nd E3). Although a pulmonary-to-systemic blood flow
atio greater than 0.6 remained in 15 of 27 patients with
bstructed pulmonary venous drainage 12 hours after the
peration, the ratio decreased significantly to less than 0.6
uring a mean time of 45 15 hours (range 15-60 hours) in
2 patients.
It is pertinent to state that, in this study group, the vertical
ein was left unligated only in patients (n  27) demon-
trating systemic or suprasystemic PA pressure and unstable
emodynamics. Patients with obstructive TAPVC who ex-
ibited moderate post-CPB PA hypertension with stable
emodynamics (n  13) underwent concomitant vertical
ein ligation. The SPAP in this subgroup of patients de-
reased to around half systemic during the operation. Sub-
equently, after initial 24 hours, 23 patients (group I n  4;
roup II n  19) had paroxysmal pulmonary hypertensive
rises. These hypertensive episodes were more frequent and
evere in patients with a ligated vertical vein. Despite insti-
ution of pulmonary vasodilators, 6 patients of the ligated
roup (19.4%) and 2 patients of the unligated group (7.4%)
y 2007
ud
h
o
(
d
t
v
T
p
m
s
i
P
n
h
a
O
w
o
v
v
f
e
r
l
g
t
i
m
2
s
i
1
s
n
h
1
(
w
f
p
e
p
p
(
v
T
s
t
1
2
d
3
T
g
L
T
a
m
p
S
8
A
9
B
g
A
H
v
o
a
s
t
i
D
C
o
s
p
(
c
c
m
b
m
t
c
p
u
m
p
p
c
h
t
r
Chowdhury et al
CH
Dltimately died of these hypertensive episodes. The risk of
eath from pulmonary hypertensive crisis was 2.9 times
igher (95% CI 1.25-6.75, P  .013) for patients who had
bstructive TAPVC and underwent vertical vein ligation
Table E2). Serial echocardiography during these episodes
emonstrated left-to-right shunting through the patent ver-
ical vein in all cases, clearly documenting the vertical
ein’s role as a temporary vent.
Before the operation, of 30 patients with obstructive
APVC, 4 patients exhibited a small indexed individual
ulmonary vein size and 2 patients had a small-sized pul-
onary venous confluence. Autopsy findings documented a
mall pulmonary venous confluence, diffuse hypoplasia,
ntimal hypertrophy, and increased medial thickness of the
As and veins in 4 nonsurvivors (group I n  2; group II
 2). Two patients of group II who died of paroxysmal
ypertensive crises exhibited pulmonary lymphangiectasia
nd interstitial emphysema on postmortem examination.
ne patient undergoing vertical vein ligation could not be
eaned from CPB because of massive intrapulmonary hem-
rrhage. Before the operation, he was ventilated and had
entricular fibrillation and diffusely small pulmonary veins.
Eleven patients with obstructed TAPVC with unligated
ertical vein continued to have tachypnea and right heart
ailure between 1 and 2 postoperative weeks. Postoperative
chocardiograms showed unobstructed pulmonary venous
eturn into the LA, with a distended vertical vein and a large
eft-to-right shunt. The vertical vein was subsequently li-
ated through resternotomy in 4 cases, left anterolateral
horacotomy in 2 cases, and adjustable vertical vein ligature
n 5 cases. In 6 cases, on snaring of the vertical vein, the
ean LA pressure increased to 23.33 1.96 mm Hg (range
1-26 mm Hg), accompanied by acute increase of PA pres-
ure to suprasystemic levels. These patients were mechan-
cally ventilated with an inspired oxygen fraction of 0.8 and
0 ppm nitric oxide and were administered pulmonary va-
odilators (sodium nitroprusside 0.5 g/[kg · min], phe-
oxybenzamine 0.5 mg/kg at 8-hour intervals) for 72 to 96
ours. Subsequently, the mean LA pressure decreased to
7.33  1.63 mm Hg (range 16-20 mm Hg) in all patients,
P  .001), all of whom had an uneventful recovery.
By univariate analysis, age younger than 1 month,
eight less than 50th percentile, obstructed drainage, dif-
usely hypoplastic pulmonary veins, presence of severe
ulmonary hypertension, ligated vertical vein in the pres-
nce of preoperative PA hypertension, emergency surgery,
ostoperative pulmonary hypertensive crises, and low out-
ut syndrome were significant negative factors for survival
Table E1). Furthermore, with this strategy of selective
ertical vein patency, the ligated vertical vein group with
APVC of the obstructed variety demonstrated statistically
ignificantly higher incidences of postoperative right ven-
ricular dysfunction, low cardiac output (RR 2.4, 95% CI W
The Journal of Thoracic.48-3.9, P  .007] and pulmonary hypertensive crisis (RR
.28, 95% CI 1.31-3.96, P  .002].
Multivariate analysis identified only seven predictors for
eath after TAPVC repair (Table E2). The risk of death was
.28 times higher (95% CI 1.08-9.99) for patients with
APVC and PA hypertension undergoing vertical vein li-
ation than in the unligated group.
ate Outcomes
here were no late deaths. Follow-up was 100% complete
nd ranged from 1 to 104 months (mean 33.34  29.88
onths, median 30 months). The total follow-up was 130.6
atient-years, with mean survival times of 96  5 (mean 
E) months (95% CI 86-107 months), for group I and 71 
(mean SE) months (95% CI 55-86 months) for group II.
t 33.34  29.88 months, the actuarial survivals were
2.6%  0.05% in group I and 71.0%  0.08% in group II.
y log-rank test, the difference in survival between the two
roups was statistically significant (P  .037; Figure E3).
ll survivors of groups I and II (n  47) were in New York
eart Association functional class I or II at last follow-up
isit. Vertical vein patency did not affect late postoperative
utcome. There were no reoperations in the late postoper-
tive period. At a mean follow-up of 33.34 29.88 months,
erial 2-dimensional echocardiography failed to reveal flow
hrough the unligated ascending or descending vertical vein
n the remaining 14 patients.
iscussion
areful analysis of published series substantiates improved
utcomes of TAPVC repair with time.1-5 The management
trategies leading to this improvement include aggressive
reoperative stabilization, improved diagnostic accuracy
with echocardiography often obviating the need for cardiac
atheterization), improvement in myocardial protection,
reation of a large, tension-free anastomosis, precise geo-
etric alignment of the pulmonary venous chamber with the
ody of the LA (avoiding torsion and rotation of the pul-
onary veins), introduction of phenoxybenzamine and ni-
ric oxide in the management of pulmonary hypertensive
rises, and delayed sternal closure.1-5
Despite introduction of these management strategies,
ostoperative low output persists in a subset of patients
ndergoing repair of obstructive TAPVC.1-5 Recurrent pul-
onary hypertensive crises, rapid development of PA and
ulmonary venous medial hypertrophy, and small, noncom-
liant LA and LV have been variously implicated as the
ausative factors for low output syndrome.1-9
The important factors that may have contributed to a
igh overall mortality (18.9%) in this study are late presen-
ation, failure of early recognition (and thus delayed refer-
al), and underdeveloped infants. This is in contrast to theest, where most patients (50%) are operated on before
and Cardiovascular Surgery ● Volume 133, Number 5 1291
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D month of age.1-4,8,10,11 Late referral is also responsible for
he development of severe pulmonary hypertension, a pro-
onged period of malnutrition, and ultimately cardiac ca-
hexia. In our earlier publication, we demonstrated that
hese patients are predisposed toward pulmonary infection,
epsis, and postoperative intrabronchial hemorrhage and
hat they react unfavorably to such stresses as CPB and
ostoperative events.5
The mechanisms causing heightened pulmonary vasore-
ctivity after repair of TAPVC are multifactorial and may
eflect release of platelet-activating factors, endothelin, and
rachidonic metabolites from pulmonary endothelial cells;
ecreased ratio of prostacyclin to thromboxane; and a
reater decline or absence of acetylcholine responsive-
ess.1-11 Many agents have been advanced as optimal on the
rounds that they selectively reduce pulmonary vascular
esistance, but few do so, and no clearly superior agent has
een identified. In this study, varying combinations of fen-
anyl, hyperventilation, correction of acidosis, inhaled nitric
xide, sodium nitroprusside, and phenoxybenzamine were
herefore used to decrease the prevalence and severity of
ulmonary hypertensive crises. Thirty patients in this series
ith obstructive supracardiac and infracardiac lesions had
trial septal fenestration. During pulmonary hypertensive
rises with limited right ventricular output and elevated
entral venous pressure, a fenestrated ASD permitted right-
o-left shunting, increasing left ventricular preload and car-
iac output, albeit at the expense of some degree of systemic
esaturation.
Previous investigators have concluded that there are four
natomic and physiologic issues involved in a subset of
atients with obstructed TAPVC. The issues are (1) struc-
urally smaller left-sided chambers, (2) a noncompliant and
ysfunctional left ventricle, (3) transient increase in pulmo-
ary vascular resistance (disease-related or CPB-related
eightened pulmonary vasoreactivity), and (4) increased
ulmonary vascular resistance as a result of increased me-
ial thickness of the pulmonary vasculature. Such chamber
bnormalities have been attributed to reduced atrial filling
nd chamber underloading as a result of a large left-to-right
hunt and decreased left ventricular diastolic pressure vol-
me relation related to elevated right ventricular diastolic
ressure or volume.12-14 It is noteworthy that all patients
ith preoperative obstructive pulmonary venous drainage in
his study (n  30) had SPAP greater than 50 mm Hg and
mean right-to-left ventricular pressure ratio of 1.2  0.02
m Hg (Table 1). To allow the left side of the heart to adapt
o and maintain adequate cardiac output, we used redundant
acron polyester fabric or pericardial patches to close the
SD and incorporated part of the vertical vein to achieve
tructural alignment and augmentation of the LA cavity.
ther investigators have reported a two-patch technique of
A enlargement to increase atrial compliance.4,15 Subse- fl
292 The Journal of Thoracic and Cardiovascular Surgery ● Mauently, several investigators have demonstrated increased
ncidence of supraventricular arrhythmias as a result of
ransversal right atrial incision and division of the crista
upraventricularis.1-4 We have not used this technique.
Reports addressing the issue of unligated vertical vein
nd postoperative hemodynamics are limited and controver-
ial.10,11,16-18 As yet, there is no fool-proof formula for
election of candidates for keeping the vertical vein patent.
raditionally, most surgeons have emphasized routine liga-
ion of the vertical vein at the time of rechanneling of
APVC repair to prevent the perceived consequence of a
esidual left-to-right shunt.1-5 Some investigators, however,
ave recently demonstrated that the practice of routine
nterruption of the vertical vein is unnecessary and may
ctually be undesirable for patients with small left heart
hambers. It is conjectured that the unligated vertical vein
ay serve as a temporary pop-off valve, allowing the left
eart chambers adequate time for growth and functional
daptation.10,11,16-18
In this series, the decision to keep the vertical vein patent
as made after the occurrence of systemic or suprasystemic
A pressure after coming off CPB on snaring the vertical
ein (Table E3). In the absence of anastomotic stricture, this
ndesirable effect can be explained by decreased unloading
f the pulmonary venous chamber caused by noncompliant
eft-sided chambers. Incorporation of the vertical vein re-
ulted in increasing the size of the LA by inclusion of this
enous reservoir, served to lower the PA and vertical vein
ressures almost immediately, and at the same time acted as
pop-off valve to the systemic venous system during epi-
odes of pulmonary hypertensive crisis. It is conceivable
hat leaving a calibrated atrial septal fenestration might also
elp to decompress the small LA after repair. Thus the
nligated vertical vein in conjunction with a calibrated atrial
eptal fenestration resulted in equalization of LA and central
enous pressures and was the automatic choice to avoid a
ismal outcome in the perioperative period.
The unligated vertical vein group (group I) demonstrated
tatistically significant decrease in in-hospital mortality (P 
04), decreased pulmonary hypertensive crises (P  .001),
essened requirement for postoperative mechanical ventila-
ion (P  .001), shortened intensive care unit and hospital
tays (P  .001), and improved postoperative hemodynam-
cs (P  .001; Table 1). Logistic regression analysis ac-
ounting for the effects of other factors demonstrated 3.28
imes (95% CI 1.08-9.99) increased risk of death after
ertical vein ligation in the setting of obstructed TAPVC
ith pulmonary hypertension (Table E2).
On the other hand, despite keeping the vertical vein
pen, 2 patients (7.4%) died early postoperatively of recur-
ent pulmonary hypertensive crisis and low cardiac output.
utopsy findings documented small pulmonary venous con-
uence, diffuse hypoplasia, intimal hypertrophy, and in-
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Dreased medial thickness of the pulmonary vasculature in 4
onsurvivors (group I n  2, group II n  2). Two patients
f group II who died of paroxysmal pulmonary hypertensive
risis exhibited pulmonary lymphangiectasia and interstitial
mphysema on postmortem examination. Anatomic studies
y others have shown that preoperative pulmonary venous
bstruction is associated with increased medial thickness in
oth PAs and veins that exceeds by far the degree of change
bserved in other lesions with pulmonary hypertension
aused by left-to-right shunts alone.19,20
On the basis of these observations, we speculate that the
edial and intimal changes seen in preoperative obstruction
ay predispose toward the development of intrinsic pulmo-
ary vein stenosis and that a patent vertical vein in this
ubset of patients does not exert favorable effects on mor-
idity and outcome after surgery, even in the presence of
dequate pulmonary venous decompression. In light of the
leak prognosis for this subset of patients, alternative man-
gement strategies such as lung transplantation may perhaps
e considered for them.21
Contrary to the report by Cope and colleagues,10 in
hich the patent venous pathway atrophied, 11 of 23 sur-
ivors of obstructive supracardiac TAPVC in this study
howed symptoms of a large left-to-right shunt through the
nligated vertical vein. Although delayed closure of the
ertical vein was successful in all cases, with concomitant
levation of PA pressure, it was attended by extremely high
A pressure in 6 patients and proved a difficult postopera-
ive challenge. These findings indicate the presence of a
elatively small, noncompliant, dysfunctional left-sided
hambers or of disease-related or CPB-related pulmonary
asoreactivity. Serial postoperative Doppler echocardiogra-
hy (mean follow-up 33.34  29.88 months) showed grad-
al decrease of blood flow through the vertical vein and
ncrease of left heart volume in the remaining 14 survivors
f group I. There was no flow through the unligated vertical
ein in both patients with infracardiac TAPVC. We concur
ith the observation of Jegier and associates18 that high
esistance of the hepatic capillary bed accounts for the
ermination of flow through the descending vertical vein.
hese observations support our contention that for an unli-
ated vertical vein to undergo spontaneous closure, the left
eart chambers must achieve normal size and function. As
uggested by Cope and colleagues,10 the development of a
ersistent left-to-right shunt through an unligated vertical
ein does not necessarily relegate a patient to a second
peration. Such candidates may be subjected to percutane-
us angiographic vertical vein embolization.
On the basis of our results, we recommend the following
uidelines for candidate selection: (1) Significant elevation
f PA or LA pressure on snaring or ligation of the vertical
ein after achievement of an adequate unrestrictive anasto-
osis is a useful clinical indicator of impaired LA compli- t
The Journal of Thoracicnce or disease-related or CPB-related pulmonary vasore-
ctivity. The vertical vein in such patients with obstructive
APVC and pulmonary hypertension may be left unligated
f post-CPB PA pressure remains systemic or suprasys-
emic. (2) Patients with nonobstructed TAPVC with or
ithout mild pulmonary hypertension will in general do
ell with vertical vein ligation. (3) The high mortality in the
igated group indicates revision of our selection criteria to
elect more appropriate candidates for a patent vertical vein.
hus patients with obstructed TAPVC with moderate post-
PB pulmonary hypertension should have an unligated
ertical vein, if there is a true benefit. (4) The requirement
f second-stage operation for closure of the vertical vein in
percentage of patients with persistent left-to-right shunt
nd right heart failure does not warrant modification of our
election criteria for unligated vertical vein. The routine use
f percutaneously adjustable vertical vein ligature in pa-
ients with obstructive supracardiac TAPVC with a discern-
ble vertical vein and pulmonary hypertension allows grad-
al tightening or loosening of the ligature under optimal
hysiologic conditions without reoperation until the pulmo-
ary vasoreactivity disappears. (5) A small ASD should be
eft open for all patients with TAPVC with moderate pul-
onary hypertension for right ventricular decompression in
he event of perioperative pulmonary hypertensive crisis.
6) Regardless of the patent vertical vein, a subset of pa-
ients with obstructed TAPVC and very small individual
ulmonary veins are at prohibitively increased risk for death
fter surgery. The findings of increased medial thickness of
he intrapulmonary vasculature on postmortem examination
uggest alternative management strategies for this subgroup
f patients.
tudy Limitations
irst, because this is a prospective study, follow-up is nec-
ssarily shorter than follow-up in previous, retrospective
tudies. Second, this study was not randomized. The occur-
ence of elevated PA pressure after coming off CPB on
naring the vertical vein was the determining factor for
eaving the vertical vein open. Thus a prospective, random-
zed, controlled trial was not performed. Finally, the small
umbers of patients and events in each subgroup are addi-
ional limitations.
onclusions
e conclude that unligated vertical vein during repair of
bstructed TAPVC is associated with decreased episodes of
ulmonary hypertensive crisis and postoperative low output
yndrome, lessened durations of ventilation and inotropic
upport, provided early normalization of hemodynamics,
nd decreased in-hospital mortality. Despite improved he-
odynamics associated with selective vertical vein patency,he postoperative course of a subset of patients with ob-
and Cardiovascular Surgery ● Volume 133, Number 5 1293
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Dtructed TAPVC and very small individual pulmonary veins
s complex, and the prognosis is poor. For an unligated
ertical vein to undergo spontaneous closure, the left heart
hambers must achieve normal size and function.
We propose routine use of an adjustable ligature around
he vertical vein in all patients with supracardiac TAPVC
ith more than moderate post-CPB pulmonary hyperten-
ion. Such a band will allow easy tightening in increments,
ith gradual increase of ventricular afterload without the
eed for multiple reoperations.
The authors are grateful to Mr Shankar Sharma for preparation
f the manuscript.
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DABLE E1. Univariate predictors of mortality at 0 to 104 mo
onnection with and without vertical vein ligation
No.
ge
1 mo 14
1 mo 44
ody weight
50th percentile 31
50th percentile 27
natomic type
Supracardiac 53
Others (infracardiac and mixed) 5
bstructive TAPVC
Yes 30
No 28
iffusely hypoplastic pulmonary veins and small
pulmonary venous confluence
Yes 6
No 52
reoperative severe pulmonary arterial hypertension
(50 mm Hg)
Yes 30
No 28
reoperative RVSP/LVSP
1.2  0.2 30
0.7  0.2 28
reoperative ventilation
Yes 9
No 49
reoperative inotropes
Yes 13
No 45
iming of surgery
Emergency 28
Elective 30
ertical vein
Ligated 31
Unligated 27
bstructive TAPVC
Ligated 13
Unligated 17
ulmonary hypertensive crises
Yes 23
No 35
ostoperative low cardiac output
Yes 25
No 33
D, Hospital death; TAPVC, total anomalous pulmonary venous connectionths after rechanneling of total anomalous pulmonary venous
HD Risk ratio 95% Confidence interval P value
6 3.20 1.40-7.35 .026
5
9 1.75 1.16-2.64 .036
2
11 1.12 1.01-1.24 .57
0
9 1.83 1.20-2.79 .026
2
4 8.56 1.79-40.9 .009
7
9 1.83 1.20-2.79 .026
2
9 1.83 1.20-2.79 .026
2
1 0.53 0.07-3.84 .86
10
2 0.78 0.2-3.02 .999
9
9 2.02 1.30-3.16 .013
2
9 1.75 1.16-2.64 .036
2
7 2.72 1.27-5.83
2 .02
8 2.28 1.31-3.96 .002
3
9 2.40 1.48-3.90 .007
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DABLE E2. Predictors of mortality at 0 to 104 months by stepwise logistic regression analysis applied to all 58 patients
tep 6 variables (covariates adjusted) Exp (B) 95% Confidence interval P value
ge (1 mo) 2.70 1.12-6.53 .027
bstructive TAPVC 2.77 1.17-6.58 .02
ypoplastic pulmonary venous confluence, diffusely hypoplastic pulmonary veins 4.67 1.73-12.61 .002
ulmonary arterial hypertension 2.29 1.00-5.24 .05
ulmonary hypertensive crisis 2.90 1.25-6.75 .013
ow cardiac output 2.93 1.28-6.73 .011
ertical vein (ligated/unligated, 1/0) 3.28 1.08-9.99 .032APVC, Total anomalous pulmonary venous connection.ABLE E3. Postbypass hemodynamic profile of patients with supracardiac total anomalous pulmonary venous connection
nd unligated vertical vein (group I) with and without snaring of the same (n  25)
ariable Snared vertical vein Unsnared vertical vein P value
ulmonary arterial pressure (mm Hg) .001
Mean  SD 86.07 10.12 54.78 7.98
Range 65-110 38-74
Median 86 55
ystemic arterial pressure (mm Hg) .001
Mean  SD 69.78 6.94 94.52 6.92
Range 50-75 80-110
Median 72 94
eft atrial pressure (mm Hg) .001
Mean  SD 18.74 1.56 12.89 1.45
Range 16-21 11-16
Median 19 12
VSP/LVSP .001
Mean  SD 1.21 0.12 0.59 0.14
Range 1.0-1.4 0.4-1.1
Median 1.2 0.6VSP/LVSP, Right-to-left ventricular systolic pressure ratio.
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DFigure E3. Actuarial survival (Kaplan–Meier) curve of two groups of patients undergoing rechanneling of total
anomalous pulmonary venous connection with or without vertical vein ligation.294.e4 The Journal of Thoracic and Cardiovascular Surgery ● May 2007
